Patent ID: 8986679
Filing Date: 2015-03-24
Classification: A61K,A61P,C12N,G01N

Abstract:
1. A method of treating a cellular proliferative disorder in a subject, the method comprising: obtaining a bodily fluid sample containing a plurality of cells, incubating the sample with EDTA or heparin in a container until the sample is separated into an upper layer and a lower layer, collecting the upper layer, isolating from the upper layer a population of somatic stem cells that are 0.3-6.0 micrometers in size and CD9+, differentiating the somatic stem cells to dendritic cells in a medium containing GCSF, SCF, EGF, PDGF, bFGF, and IL-3, the dendritic cells being CD83+ and CD86+, purifying the dendritic cells, contacting the dendritic cells thus purified with a cancer antigen, and administering an effective amount of the dendritic cells presenting the cancer antigen to a subject in need thereof.